Cardiovascular Medicine

6 pages, 1220 KB

Open AccessArticle

Regelmässige Breitkomplextachykardie bei Dekrementaler Präexzitation

by Ardan M. Sagunera, Andreas Metzner, Sebastian Deiss, Tilman Maurer, Christine Lemes, Kentaro Hayashi, Christian Heeger, Karl-Heinz Kuck, Feifan Ouyang and Erik Wissner

Cardiovasc. Med. 2015, 18(10), 4; https://doi.org/10.4414/cvm.2015.00353 - 21 Oct 2015

Viewed by 10

Abstract

Ein 46-jähriger Mann stellte sich aufgrund von wöchentlich auftretenden Palpitationen mit plötzlichem Beginn und abruptem Ende (on–off) in unserer Ambulanz vor. Diese bestünden seit dem 15. Lebensjahr, hätten jedoch in den letzten Monaten an Häufigkeit und Dauer zugenommen und würden sowohl in Ruhe als auch unter Belastung aureten. Vagale Manöver habe er nicht versucht, da die Palpitationen jeweils spontan nach wenigen Minuten terminierten. Full article

1 pages, 97 KB

Open AccessEditorial

20. Zürcher HerzKreislauftag

by Ruth Amstein

Cardiovasc. Med. 2015, 18(10), 294; https://doi.org/10.4414/cvm.2015.00365 - 21 Oct 2015

Viewed by 9

Abstract

Ein Jahresrückblick bietet Gelegenheit für eine Standortbestimmung [...] Full article

3 pages, 1115 KB

Open AccessCase Report

Prolonged Complete AV Block After Balloon Aortic Valvuloplasty in a Child

by Dina-Maria Jakob, Sabine Pallivathukal, Bernhard Meier and Jean-Pierre Pfammatter

Cardiovasc. Med. 2015, 18(10), 285; https://doi.org/10.4414/cvm.2015.00357 (registering DOI) - 21 Oct 2015

Viewed by 8

Abstract

A case is presented of prolonged complete atrioventricular block after elective balloon aortic valvuloplasty (BAV) of a congenital aortic stenosis in a 10-year-old patient. Implantation of a transient transvenous pacemaker for hemodynamic stabilization was required. Stable sinus rhythm reoccurred 72 hours after BAV. [...] Read more.

3 pages, 85 KB

Open AccessArticle

Timely Diagnosis of Congenital Heart Disease–Did We Improve?

by Andrea Keuffer and Jean-Pierre Pfammatter

Cardiovasc. Med. 2015, 18(10), 282; https://doi.org/10.4414/cvm.2015.00363 - 21 Oct 2015

Cited by 1 | Viewed by 8

Abstract

Introduction: Delayed recognition of congenital heart disease (CHD) is not infrequent and may have a negative impact on the child’s prognosis. A study from our institution published in 2001 showed a rate of late diagnosis as high as 10% of all relevant CHD requiring therapy, and this rate was equal in cyanotic and acyanotic CHD. Methods: A study identical to the one 12 years ago was performed with prospective evaluation of the time of first diagnosis of CHD during a 3-year period ending in June 2011. Only CHD that required surgical or catheterbased treatment was included. Late diagnosis was defined as diagnosis of CHD after discharge from the birth hospital for cyanotic CHD; for acyanotic CHD it was defined as first diagnosis at a time when therapy should already have taken place in accordance with recommended standards or if immediate treatment was necessary at the time of CHD recognition. In between the two studies came the recommendation of a nationwide neonatal pulse oximetry screening, starting in 2006. Results: A total of 209 patients were included, 41% of these had cyanotic and 59% had acyanotic CHD. According to the entry criteria, late diagnosis was observed in 21 patients (10% of total population); 6% of cyanotic CHD patients (5 of 85) and 13% of acyanotic CHD patients (16 of 124). The two most frequently missed CHDs were atrial septal defect and coarctation (seven and six patients, respectively). Delayed diagnosis resulted in one death (unrecognised interrupted aortic arch in one neonate). Compared with the historical study in our referral population the main finding was that the total number of late diagnoses remained stable at 10%, with a slight decrease only in the rate of late diagnosed cyanotic CHD (from 10 to 6%) but with a rise in late diagnosed acyanotic CHD from 10 to 13% of all patients observed. Conclusions: After 12 years of referring physician education and the implementation of a nationwide neonatal pulse oximetry screening, the rate of late diagnosis of CHD remained unchanged at 10% of all patients with only the rate of cyanotic CHD showing a slight decline. Full article

9 pages, 208 KB

Open AccessReview

The Weak Heart: Perioperative Management

by Dominique Anne Bettex, Pierre-Guy Chassot and Alain Rudiger

Cardiovasc. Med. 2015, 18(10), 273; https://doi.org/10.4414/cvm.2015.00362 - 21 Oct 2015

Viewed by 13

Abstract

Heart failure (HF) is known to be a major risk factor in perioperative care. It should be subdivided into systolic or diastolic dysfunction as well as left or right ventricular failure. The perioperative management of HF patients is complex, consisting of prevention, diagnosis and therapy. The adequacy of the perioperative management determines the late postoperative outcome and will be presented in this review. Full article

6 pages, 3307 KB

Open AccessViewpoint

Percutaneous Coronary Intervention, Not All Roads Lead to Rome

by Bernhard Meier

Cardiovasc. Med. 2015, 18(10), 267; https://doi.org/10.4414/cvm.2015.00364 (registering DOI) - 21 Oct 2015

Viewed by 9

Abstract

Percutaneous coronary intervention (PCI) started with a first patient in Zurich, Switzerland, treated by Andreas Grüntzig on September 16, 1977. Having been part of that intervention, I enjoy the privilege of taking care of this patient since. He is still enjoying excellent health and needed only two additional percutaneous interventions in his coronary arteries after 23 and 37 years, respectively. PCI saw an unprecedented evolution to today’s role as the most common major medical intervention around the globe. As is typical for a success story, many people have been co-builders. Even more people have tried to contribute to PCI or even replace it with modifications or alternatives that do not benefit patients. This was not always recognised immediately but the only real breakthrough, the coronary stent, was finally recognised by all as the only necessary adjunct to the initial balloon. The achieved degree of perfection of PCI will make it hard, if not impossible, to improve upon it by a change of paradigm, while small adaptations will continue to be introduced because they do not need randomised trials for approval. Full article

► Show Figures

Graphical abstract

Journal Menu

Journal Browser

Cardiovasc. Med., Volume 18, Issue 10 (10 2015) – 6 articles

Further Information

Guidelines

MDPI Initiatives

Follow MDPI